Literature DB >> 19210859

Ultrasound imaging for the rheumatologist. XVIII. Ultrasound measurements.

G Meenagh1, E Filippucci, A Delle Sedie, L Riente, A Iagnocco, O Epis, C A Scirè, C Montecucco, S Bombardieri, G Valesini, W Grassi.   

Abstract

One of the largest challenges to the field of musculoskeletal ultrasonography is attempting to accurately quantify the changes seen in chronic arthritis. With advances in ultrasound technology, researchers have been increasingly exploring ways of more accurately assessing these changes and attempting to reach consensus with agreed scoring systems. This review presents the main scoring systems developed for quantifying sonographic findings indicative of synovitis and joint damage in patients with rheumatoid arthritis. Further investigation is required to attain international consensus on such scoring systems and to evaluate their impact on therapeutic decision-making.

Entities:  

Mesh:

Year:  2008        PMID: 19210859

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger.

Authors:  Tamotsu Kamishima; Kazuhide Tanimura; Masato Shimizu; Megumi Matsuhashi; Jun Fukae; Yujiro Kon; Hiromi Hagiwara; Akihiro Narita; Yuko Aoki; Naoki Kosaka; Tatsuya Atsumi; Hiroki Shirato; Satoshi Terae
Journal:  Skeletal Radiol       Date:  2010-11-14       Impact factor: 2.199

2.  Quantitative power Doppler signal assessment in the subchondral bone region of the metacarpophalangeal joint is an effective predictor of radiographic progression in the hand of rheumatoid arthritis: a pilot study.

Authors:  Motoshi Fujimori; Tamotsu Kamishima; Akihiro Narita; Mihoko Henmi; Masaru Kato; Kenneth Sutherland; Mutsumi Nishida; Yuki Tanaka; Lu Yutong; Kazuhide Tanimura; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2019-05-14       Impact factor: 2.631

3.  Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.

Authors:  Serena Bugatti; Antonio Manzo; Francesca Benaglio; Catherine Klersy; Barbara Vitolo; Monica Todoerti; Garifallia Sakellariou; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Arthritis Res Ther       Date:  2012-02-15       Impact factor: 5.156

4.  A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.

Authors:  Fabrizio Vincenzi; Melissa Padovan; Martina Targa; Carmen Corciulo; Sarah Giacuzzo; Stefania Merighi; Stefania Gessi; Marcello Govoni; Pier Andrea Borea; Katia Varani
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.